METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo targets Hard-to-Treat esophageal cancer
Disease control OngoingThis early-stage trial tested a drug called adavosertib combined with radiation for people with advanced esophageal or stomach cancer that cannot be removed by surgery. The goal was to find the safest dose and see how well the combination works. Only 4 people took part, so result…
Matched conditions: METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 00:53 UTC
-
New drug combo shows promise for tough esophageal cancer
Disease control OngoingThis study tests whether adding the drug cixutumumab to standard chemotherapy (paclitaxel) can help people with esophageal cancer that has spread. About 94 adults with metastatic esophageal or gastroesophageal junction cancer will receive either paclitaxel alone or paclitaxel plu…
Matched conditions: METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
New Three-Drug cocktail shows promise against tough esophageal cancer
Disease control OngoingThis study tests whether adding lenvatinib to standard pembrolizumab plus chemotherapy helps people with metastatic esophageal cancer live longer. About 864 participants will receive either the three-drug combo or the standard two-drug treatment. The goal is to see if the new com…
Matched conditions: METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 08, 2026 12:01 UTC